Biolife solutions stock.

Description. BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted ...16 mar 2023 ... Share this article · Cell Processing platform revenue was $68.5 million, up $23.5 million, or 52%, over 2021. · Freezers and Thaw Systems platform ...BOTHELL, Wash., Oct. 4, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced a broad engagement with a leading cell therapy developer, wherein BioLife's CryoStor freeze …$12.75. As on 28-Nov-2023 16:00 EST. up-down-arrow $-0.69 • -5.13% · Prev Close info. $13.44 · Day's Open info. $13.38 · Today's High info. $13.55 · Today's Low ...Stock Information. The interactive chart below shows a historical timeline of our stock price and trading volume. Click on the tabs below to view the different timeframes. You may also view data on Dividend, Split, and Earning History by using the Events tab. NASDAQBLFS. 5d. 1m. 3m. 6m.

BOTHELL, Wash., March 22, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced the signing of a definitive merger agreement to acquire Global Cooling, Inc., operating as …BioLife Solutions, Inc. is a life sciences company. The Company develops, manufactures, and markets bioproduction tools and services which are designed to de-risk biologic manufacturing, storage, distribution, and transportation in the cell and gene therapy (CGT) industry and broader biopharma markets.

Dec 4, 2023 · Biolife Solutions Inc (NASDAQ:BLFS) has a beta value of 1.60 and has seen 2.24 million shares traded in the last trading session. The company, currently valued at $596.91M, closed the last trade at $13.25 per share which meant it gained $0.88 on the day or 7.11% during that session. The BLFS stock ... BOTHELL, Wash., April 15, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced that it has launched a new line of high capacity controlled rate freezers (HCRF), with an …

When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll want to ensure that you find the best one available in stock.BOTHELL, Wash., Jan. 10, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy (CGT) and broader biopharma markets, today announced preliminary revenue for the fourth quarter and full year 2021.BioLife Solutions, Inc. (BLFS) Stock Price, Quote, News & Analysis BLFS BioLife Solutions, Inc. Stock Price & Overview 5.43K followers $10.95 -0.44 ( -3.86%) 4:00 PM 11/10/23 NASDAQ...Maximize post-thaw cell recovery and viability following cryopreservation at low temperatures (-80°C to -196°C) with ready-to-use CryoStor® CS5. Serum-free, animal component-free, and cGMP-manufactured, this defined medium provides a safe, protective environment for cells and tissues during freezing and thawing processes and storage.Shares of BioLife Solutions (BLFS 7.11%) were down more than 37% for the week, as of 3:15 p.m. ET on Friday, ... The healthcare company's stock closed last week at $19.22, then dropped to a 52 ...

The BioLife Solutions stock price gained 3.76% on the last trading day (Friday, 24th Nov 2023), rising from $13.57 to $14.08. During the last trading day the stock fluctuated 11.10% from a day low at $12.79 to a day high of $14.21. The price has risen in 6 of the last 10 days and is up by 23.62% over the past 2 weeks.

Oct 19, 2023 · Broadridge Corporate Issuer Solutions, Inc. P.O. Box 1342 Brentwood, New York 11717 USA (877) 830 - 4936 [email protected]

Under the terms of the agreement, BioLife will pay $15 million in cash and $15 million in newly issued shares of BioLife common stock for 100% of the outstanding shares of SciSafe. ... About BioLife Solutions BioLife Solutions is a leading supplier of a portfolio of class-defining cell and gene therapy bioproduction tools and services.BOTHELL, Wash., Aug. 9, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapies ("CGT") and the broader biopharma markets, today announced financial results for the three and six months ended ...BioLife Solutions, Inc. : News, information and stories for BioLife Solutions, Inc. | Other OTC: | Other OTCOn December 15, 2022, BioLife Solutions, Inc. (NASDAQ:BLFS) stock closed at $18.77 per share. One-month return of BioLife Solutions, Inc. (NASDAQ:BLFS) was -11.46%, and its shares lost 48.63% of ...BioLife Sciences is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. 2831 Saint Rose Parkway Suite 200 Henderson, NV 89052 United StatesJun 26, 2020 · Hedge fund activity in BioLife Solutions, Inc. (NASDAQ:BLFS) Heading into the second quarter of 2020, a total of 9 of the hedge funds tracked by Insider Monkey were long this stock, a change of ... BioLife Solutions stock scales 10% on acquisition of Stirling Ultracold SA News Mon, Mar. 22, 2021 4 Comments BioLife Solutions EPS misses by $0.01, beats on revenue

Nov 15, 2023. Currency in USD. Quote data delayed by at least 15 minutes. Earnings and Analyst data provided by Zacks. Insiders data provided by Morningstar. CONTACT.Complete BioLife Sciences Inc. stock information by Barron's. View real-time BLFE stock price and news, along with industry-best analysis.Maximize post-thaw cell recovery and viability following cryopreservation at low temperatures (-80°C to -196°C) with ready-to-use CryoStor® CS5. Serum-free, animal component-free, and cGMP-manufactured, this defined medium provides a safe, protective environment for cells and tissues during freezing and thawing processes and storage.Culture supplement to replace FBS or AB Serum. Biodefined composition reduces lot-to-lot variability. Supports a wide range of cell types including MSCs, T-Cells, NK Cells, Endothelial cells, and more. Promotes improved in vitro and In vivo cell quality in CAR-T applications. Typically used at concentrations ranging from 2% to 10%.BioLife Solutions, Inc. (BLFS) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the ...

BioLife recently disclosed its financial results for the fourth quarter of 2022, showcasing solid revenue growth and a better gross margin. In Q4 2022, the company brought in $44.3 million in ...According to the issued ratings of 5 analysts in the last year, the consensus rating for BioLife Solutions stock is Buy based on the current 5 buy ratings for BLFS. The average twelve-month price prediction for BioLife Solutions is $24.60 with a high price target of $28.00 and a low price target of $22.00. Learn more on BLFS's analyst rating ...

20 sept 2022 ... About BioLife Solutions Stock ... Today, BioLife has a market cap of just over $1 billion, with total revenue of $119.2 million in 2021, an ...Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...7 dic 2020 ... Thomas Girschweiler sold 1600000 shares, an approximate value of $36 million, of the BioLife Solutions' stock to Casdin Capital LLC.BioLife Solutions (BLFS) In a report released today, Robert Wasserman from Benchmark Co. maintained a Hold rating on BioLife Solutions. The company’s shares closed last Thursday at $11.96.Oct 16, 2023 · BioLife Solutions to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 16, 2023. BOTHELL, Wash. , March 9, 2023 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and... Stock CONTACT BioLife Solutions Inc. 3303 Monte Villa Parkway, Suite 310, Bothell, WA 98021 USA T +1.866.424.6543 or 425.402.1400 F +1.425.402.1433 NAVIGATION Investors Knowledge Center Company …Discover more Overcome the challenges of cell expansion and product preservation throughout CGT processing. Independent research demonstrates the medium and material used in sample cryopreservation impacts biologic viability. Formulation must be sterile, free from adventitious agents and qualified before use to remove susceptibility from batch-to …BAC Vs BLFS: Stock comparison by Artificial Intelligence. Which is a better buy? Make smart data-driven investment decisions and get unique insights. Start now and save 50% for the first 3 months save 50% for the first 3 months. Ticker. Company. Your search produced no matches. We currently support US stocks and STOXX Europe 600 …

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies.

BioLife Solutions Reports First Quarter 2023 Financial Results. Revenue of $37.7 million increased 4% over Q1 2022, ex-COVID growth of 16% and biopreservation media revenue growth of 28%. Q1 2023 ...

BioLife recently disclosed its financial results for the fourth quarter of 2022, showcasing solid revenue growth and a better gross margin. In Q4 2022, the company brought in $44.3 million in ...Get in touch. BioLife Solutions Inc. 3303 Monte Villa Parkway, Suite 310, Bothell , WA 98021 USA. For assistance, please call us Monday through Friday (9:00 am to 5:00 pm PST) at:View the latest BioLife Solutions Inc. (BLFS) stock price, news, historical charts, analyst ratings and financial information from WSJ.Safely store valuable samples at ultra-low temperatures from -20°C to -86°C. The ULT25NEU holds 18 2-inch boxes in a portable and lightweight 25-liter (0.9 cu. ft.) size, made possible by our breakthrough ULT technology. Designed for space and energy efficiency, the ULT25NEU ultra-low temperature freezer uses less than 2.8 kWh/day at …BOTHELL, Wash., Jan. 17, 2023 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapy (CGT) and the broader biopharma markets, today announced the dates of its 2023 analyst day and …BioLife Solutions is a leading supplier of class-defining cell and gene therapy bioproduction tools and services. Our tools portfolio includes our proprietary CryoStor® and HypoThermosol ...BioLife Solutions, Inc. Common Stock (BLFS) Stock Price, Quote, News & History | Nasdaq. Nasdaq Data Link's products page. Investors may trade in the Pre-Market (4:00 …Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods that may have been lost or stolen.Get the latest BioLife Solutions Inc (BLFS) stock quote, charts, news, and other financial information to help you make more informed trading and investment decisions. See the company's financial performance, balance sheet, cash flow, and earnings per share for the fiscal Q2 2023 ended 6/30/23.

BioLife Solutions Inc (ISIN: US09062W2044, WKN: A1XCF2): ✓ Precio Acciones BioLife Solutions Inc ✓ Rendimiento de Dividendos y Fechas, ✓ News ✓ Plan de ...Sep 1, 2021 · BOTHELL, Wash., Sept. 1, 2021 / PRNewswire / -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that it has closed its acquisition of Sexton Biotechnologies ... Consensus BioLife Solutions, Inc. Equities. BLFS. US09062W2044. Market Closed - Nasdaq. Other stock markets.Instagram:https://instagram. brokers with low minimum deposithow to sell an iphone onlineroth 401k vs 401k for high income earnersavion drone insurance Maximize post-thaw cell recovery and viability following cryopreservation at low temperatures (-80°C to -196°C) with ready-to-use CryoStor® CS5. Serum-free, animal component-free, and cGMP-manufactured, this defined medium provides a safe, protective environment for cells and tissues during freezing and thawing processes and storage.A high-level overview of BioLife Solutions, Inc. (BLFS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … hd stock forecastbizd etf Open 18.44. Day High 18.95. Day Low 18.17. Prev Close 18.25. 52 Week High 26.96. 52 Week High Date 09/08/22. 52 Week Low 10.40. 52 Week Low Date 05/12/22. Market Cap 812.385M. jewelry insurance reviews BOTHELL, Wash., July 7, 2020 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced the closing of its public offering of 5,951,250 shares of common stock at the public offering price of $14.50 …BioLife Solutions Stock Price, News & Analysis (NASDAQ:BLFS) $12.51 -0.24 (-1.88%) (As of 05:28 PM ET) Compare Today's Range $12.46 $13.62 50-Day Range $8.99 …